Sensorium Therapeutics, Inc.
Pharmaceutical company · Medford, Massachusetts, United States
Sensorium Therapeutics, Inc. is a pharmaceutical company headquartered in Medford, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $27 million sold in a notice filed in 2025.
Sensorium Therapeutics at a glance
What does Sensorium Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2 million in total (2024 to 2025). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $26.8 million sold (2025).
Frequently asked questions about Sensorium Therapeutics
Where is Sensorium Therapeutics headquartered?
Sensorium Therapeutics, Inc. is headquartered in Medford, Massachusetts, United States.
What does Sensorium Therapeutics do?
Sensorium Therapeutics, Inc. is a pharmaceutical company.
When was Sensorium Therapeutics founded?
The earliest incorporation on record for Sensorium Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences